About DNA Data
DNA Data is a Healthcare company based in San Sebastian (Spain) founded in 2012 by Concha Vidales, and was acquired by Biolan in February 2023. It operates as a genetic and biological analyses are provided for diagnosing genetic diseases. It operates on a Professional Services model. Its chief executive is Concha Vidales. DNA Data offers products and services including Genetic Studies, Assisted Reproduction Diagnostics, and Fetal Exome Testing. Its focus areas include Biotechnology and Genetic Testing. Its legal entity is DNA Data SL. Its competitors include Everlywell, Viome, Color, Invitae and Counsyl and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
DNA Data is specialized in conducting genetic and biological analyses for the diagnosis of genetic diseases across various medical disciplines. Services are provided to support assisted reproduction clinics in improving reproductive success. A comprehensive fetal exome testing service is also offered to detect genetic alterations in fetuses. The company operates within the biomedical sector, focusing on innovative diagnostic solutions for a wide range of genetic pathologies.
- Headquarters San Sebastian, Spain
- Founders Concha Vidales
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dnadata.es
- Social LinkedIn X Instagram
- Acquired by Biolan (Feb 2023)
- Legal Name Dna Data Sl
Products & Services of DNA Data
DNA Data offers a comprehensive portfolio of products and services, including Genetic Studies, Assisted Reproduction Diagnostics, and Fetal Exome Testing.
Genetic studies are conducted for disease diagnosis purposes.
Diagnostics are provided for assisted reproduction clinic support.
Fetal exome testing is offered for genetic alterations.
Investors in DNA Data
DNA Data has secured backing from 1 investor. Prominent investors backing the company include Biolan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biolan is engaged in developing biosensors for food safety and health diagnostics. | 2006 | biolanmb.com | Zamudio, Spain |
Investor details for DNA Data
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of DNA Data
1 people are tracked at DNA Data (1 in leadership).
| Name | Role | Group |
|---|---|---|
Concha Vidales | Founder & CEO | Leadership |
Complete people profiles for DNA Data
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of DNA Data
2 dated milestones of DNA Data across 11 years, from founding to its latest funding, stage changes and deals.
- Founded DNA Data is founded.
- Exit Acquired by Biolan.
Competitors of DNA Data
DNA Data has 9 listed competitors in our database, 9 of them funded. They include Everlywell, Viome, Color, Invitae and Counsyl, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| geneplanet.com | 2008 | Ljubljana, Slovenia | $34.02M | – | DNA-based personalized health and fitness recommendations are offered. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| digbihealth.com | 2018 | Mountain View, United States | $5.4M | – | Personalized healthcare is delivered through DNA and gut biome testing. |
Detailed competitors of DNA Data
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DNA Data
The website of DNA Data (dnadata.es) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 32.5% vs previous month
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as DNA Data (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dna Data
Complete news archive for DNA Data
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNA Data
DNA Data was founded in 2012.
DNA Data is headquartered in San Sebastian, Spain.
Concha Vidales is the current CEO of DNA Data. They have also founded this company.
DNA Data is specialized in conducting genetic and biological analyses for the diagnosis of genetic diseases across various medical disciplines. Services are provided to support assisted reproduction clinics in improving reproductive success. A comprehensive fetal exome testing service is also offered to detect genetic alterations in fetuses. The company operates within the biomedical sector, focusing on innovative diagnostic solutions for a wide range of genetic pathologies.
DNA Data's top competitors include Viome, Variant Bio and Newtopia.
DNA Data offers Genetic Studies, Assisted Reproduction Diagnostics, and Fetal Exome Testing.
DNA Data has 1 investor. Key investors include Biolan.
DNA Data operates through Dna Data Sl.
Yes. DNA Data was acquired by Biolan in February 2023.